Cizkova_2018_Toxicol.Appl.Pharmacol_355_156

Reference

Title : Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner - Cizkova_2018_Toxicol.Appl.Pharmacol_355_156
Author(s) : Cizkova K
Ref : Toxicol Appl Pharmacol , 355 :156 , 2018
Abstract :

CYP epoxygenases metabolize arachidonic acid into four regioisomers of epoxyeicosatrienoic acids (EETs) which are hydrolysed into their corresponding diols by soluble epoxide hydrolase (sEH). EETs are very biologically active molecules. They promote proliferation and inhibit apoptosis as well as numerous other functions within organisms. Peroxisome proliferator-activated receptor alpha (PPARalpha) play role in regulation of CYP epoxygenases and sEH. PPARalpha is the ligand-dependent transcriptional factor which is activated by various compounds, including fibrates. The latter are widely used in clinical practice. This study investigates the changes in expression of CYP2C8, CYP2J2, and sEH in HEK293, HepG2, and HT-29 cell lines after fibrate treatment using two different incubation times. The results demonstrate that the effect of fibrates on arachidonic acid-metabolizing enzymes expression is concentration-dependent. Although CYP2C8 expression is downregulated by the fibrates treatment, the results reveal that changes in CYP2J2/sEH ratio are closely associated with cell proliferation and could explain the differing proliferation response of cells to different concentrations of fibrates.

PubMedSearch : Cizkova_2018_Toxicol.Appl.Pharmacol_355_156
PubMedID: 29960002

Related information

Citations formats

Cizkova K (2018)
Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner
Toxicol Appl Pharmacol 355 :156

Cizkova K (2018)
Toxicol Appl Pharmacol 355 :156